Susan Becktesh

Title: The Innovative Contributions of Susan Becktesh in Neurotrophic Protein Research

Introduction

Susan Becktesh, a remarkable inventor based in Boulder, Colorado, has made significant strides in the field of neurobiology. With one patented invention to her name, she has contributed to our understanding of neurotrophic proteins, vital components for the survival and growth of neurons in the human body.

Latest Patents

Susan's patent, titled "Production of biologically active NGF proteins," outlines advanced processes for producing mature human members of the NGF/BDNF family of neurotrophic proteins, which are fully biologically active. This invention not only details the gene encoding for the human BDNF (Brain-Derived Neurotrophic Factor) but also introduces NGF-3, a previously unidentified member of this protein family. The patent encompasses a portion of the gene encoding for NGF-3, marking a notable addition to neurobiological research.

Career Highlights

Susan Becktesh is currently affiliated with Amgen Inc., a renowned biotechnology company known for its focus on innovative medicine. At Amgen, she has been instrumental in her research and has established herself as a key player in the field of neurotrophic proteins, driving projects that can lead to groundbreaking therapeutic solutions.

Collaborations

Throughout her career, Susan has worked closely with talented colleagues, including Frank D. Collins and Jack Lile. This collaboration has fostered an environment where collective expertise can lead to significant advancements in neurobiology and therapeutic development.

Conclusion

Susan Becktesh's contributions to the field of neurotrophic protein research have significant implications for understanding neuronal development and potential treatments for neurodegenerative diseases. Her innovative spirit and dedication to scientific research embody the essence of innovation, paving the way for future discoveries in neurobiology.